Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammation in Heart Failure With Preserved Ejection Fraction
Mardi Gomberg‐Maitland, Sanjiv J. Shah, Marco Guazzi
JACC Heart Failure (2016) Vol. 4, Iss. 4, pp. 325-328
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction
Sanjiv J. Shah, Dalane W. Kitzman, Barry A. Borlaug, et al.
Circulation (2016) Vol. 134, Iss. 1, pp. 73-90
Open Access | Times Cited: 860
Epicardial Adipose Tissue May Mediate Deleterious Effects of Obesity and Inflammation on the Myocardium
Milton Packer
Journal of the American College of Cardiology (2018) Vol. 71, Iss. 20, pp. 2360-2372
Closed Access | Times Cited: 480
Role of endothelial dysfunction in heart failure
Cinzia Zuchi, Isabella Tritto, Erberto Carluccio, et al.
Heart Failure Reviews (2019) Vol. 25, Iss. 1, pp. 21-30
Closed Access | Times Cited: 148
Regional adiposity and heart failure with preserved ejection fraction
Vishal N. Rao, Marat Fudim, Robert J. Mentz, et al.
European Journal of Heart Failure (2020) Vol. 22, Iss. 9, pp. 1540-1550
Open Access | Times Cited: 93
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes
Teresa Salvatore, Raffaele Galiero, Alfredo Caturano, et al.
Biomolecules (2022) Vol. 12, Iss. 2, pp. 176-176
Open Access | Times Cited: 46
Vagus Nerve Stimulation and Inflammation in Cardiovascular Disease: A State‐of‐the‐Art Review
George Bazoukis, Stavros Stavrakis, Antonis A. Armoundas
Journal of the American Heart Association (2023) Vol. 12, Iss. 19
Open Access | Times Cited: 31
Molecular Mechanisms Underlying Heart Failure and Their Therapeutic Potential
Oveena Fonseka, Sanskruti Ravindra Gare, Xinyi Chen, et al.
Cells (2025) Vol. 14, Iss. 5, pp. 324-324
Open Access | Times Cited: 2
Autonomic Neuromodulation Acutely Ameliorates Left Ventricular Strain in Humans
Nicole Tran, Zain Ul Abideen Asad, Khaled Elkholey, et al.
Journal of Cardiovascular Translational Research (2018) Vol. 12, Iss. 3, pp. 221-230
Open Access | Times Cited: 73
What Is the Role of the Inflammation in the Pathogenesis of Heart Failure?
Elena C. Castillo, Eduardo Vázquez‐Garza, David Yee-Trejo, et al.
Current Cardiology Reports (2020) Vol. 22, Iss. 11
Open Access | Times Cited: 63
NETosis as a Pathogenic Factor for Heart Failure
Shuang Ling, Jin‐Wen Xu
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, pp. 1-24
Open Access | Times Cited: 42
CXCR4-dependent macrophage-to-fibroblast signaling contributes to cardiac diastolic dysfunction in heart failure with preserved ejection fraction
Ning Zhang, Qunchao Ma, Yayu You, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 3, pp. 1271-1287
Open Access | Times Cited: 35
Pivotal Role of Excess Intra-Abdominal Adipose in the Pathogenesis of Metabolic/Obese HFpEF
Dalane W. Kitzman, Barbara J. Nicklas
JACC Heart Failure (2018) Vol. 6, Iss. 12, pp. 1008-1010
Open Access | Times Cited: 47
Prevalence, characteristics and prognostic impact of aortic valve disease in patients with heart failure and reduced, mildly reduced, and preserved ejection fraction: An analysis of the ESC Heart Failure Long‐Term Registry
Bahira Shahim, Angiza Shahim, Marianna Adamo, et al.
European Journal of Heart Failure (2023) Vol. 25, Iss. 7, pp. 1049-1060
Open Access | Times Cited: 16
The Cardio-Renal Interrelationship
Konstantinos Dean Boudoulas, Filippos Triposkiadis, John Parissis, et al.
Progress in Cardiovascular Diseases (2016) Vol. 59, Iss. 6, pp. 636-648
Closed Access | Times Cited: 46
Reduced Myocardial Flow Reserve Is Associated With Diastolic Dysfunction and Decreased Left Atrial Strain in Patients With Normal Ejection Fraction and Epicardial Perfusion
Matthew C. Konerman, Joshua C. Greenberg, Theodore J. Kolias, et al.
Journal of Cardiac Failure (2017) Vol. 24, Iss. 2, pp. 90-100
Open Access | Times Cited: 39
Cilostazol ameliorates heart failure with preserved ejection fraction and diastolic dysfunction in obese and non-obese hypertensive mice
S. Santosh Reddy, Heena Agarwal, Manoj Kumar Barthwal
Journal of Molecular and Cellular Cardiology (2018) Vol. 123, pp. 46-57
Closed Access | Times Cited: 33
Role of epicardial adipose tissue in heart failure with preserved ejection fraction: An emerging molecular mechanism and therapeutic potential
Zhongwen Qi, Dan Wu, Zhipeng Yan, et al.
Obesity Reviews (2025)
Open Access
Drug Targets for Heart Failure with Preserved Ejection Fraction: A Mechanistic Approach and Review of Contemporary Clinical Trials
Ravi B. Patel, Sanjiv J. Shah
The Annual Review of Pharmacology and Toxicology (2018) Vol. 59, Iss. 1, pp. 41-63
Open Access | Times Cited: 24
Targets for Heart Failure With Preserved Ejection Fraction
Shane Nanayakkara, David M. Kaye
Clinical Pharmacology & Therapeutics (2017) Vol. 102, Iss. 2, pp. 228-237
Closed Access | Times Cited: 22
Mediterranean diet and prognosis of first-diagnosed Acute Coronary Syndrome patients according to heart failure phenotype: Hellenic Heart Failure Study
Matina Kouvari, Christina Chrysohoou, Panagiotis Aggelopoulos, et al.
European Journal of Clinical Nutrition (2017) Vol. 71, Iss. 11, pp. 1321-1328
Closed Access | Times Cited: 20
Prognostic Value of Epicardial Adipose Tissue in Heart Failure With Mid‐Range and Preserved Ejection Fraction: A Multicenter Study
Wenxian Wang, Yan Gao, Jian Wang, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 24
Open Access | Times Cited: 2
Immune Dysregulation in HFpEF: A Target for Mesenchymal Stem/Stromal Cell Therapy
Ruxandra Sava, Carl J. Pepine, Keith L. March
Journal of Clinical Medicine (2020) Vol. 9, Iss. 1, pp. 241-241
Open Access | Times Cited: 14
Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms
Hans Carl Hasselbalch, Peter Junker, Vibe Skov, et al.
Cancers (2023) Vol. 15, Iss. 17, pp. 4323-4323
Open Access | Times Cited: 5
Altered Expression of Intestinal Tight Junction Proteins in Heart Failure Patients with Reduced or Preserved Ejection Fraction: A Pathogenetic Mechanism of Intestinal Hyperpermeability
Eleni‐Evangelia Koufou, Stelios F. Assimakopoulos, Pinelopi Bosgana, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 160-160
Open Access | Times Cited: 1
Vagus Nerve Stimulation for the Treatment of Heart Failure
Zain Ul Abideen Asad, Stavros Stavrakis
Bioelectronics in Medicine (2019) Vol. 2, Iss. 1, pp. 43-54
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top